| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9256530 | Seminars in Colon and Rectal Surgery | 2005 | 7 Pages |
Abstract
The standard treatment for patients with primary unresectable or recurrent rectal cancer is preoperative combined modality therapy. Given the high local recurrence rate, novel approaches using IORT, new chemotherapeutic agents, and altered radiation fractionation schemes had been developed and are being actively investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Bruce D. MD,